Head-to-head · WeighScore
AZ Health vs Henry Meds
By GLP-1 ScorecardUpdated
Score comparison
Henry Meds has the higher recorded score — 77.3/100 to 69/100.
Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Henry's low monthly equivalents come with a full year paid upfront, so it is a poor fit for someone shopping for a short trial.
Before you choose
Before comparing the headline prices, the AZ Health review and the Henry Meds review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, AZ Health vs Invigor Medical and Bionomy Health vs Henry Meds compare each of them with another graded program, and the list of alternatives to AZ Health ranks the programs closest to AZ Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AZ Health | Henry Meds |
|---|---|---|
| WeighScore | 69/100 | 77.3/100 |
| Grade | C | C+ |
| Site position | #148 | #47 |
| Semaglutide | From $179/mo (injectable, compounded) | $197/mo (injectable; 12-month plan paid upfront in full, $2,364) |
| Tirzepatide | Conflicting published injectable prices | Oral compounded plans; confirm selected price and supply |
| Coverage | Coverage not published | Multi-state |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- Publishes a starting price for injectable semaglutide and separate prices for the oral tablets
- Advertises a free screening and discreet shipping
What to consider
- Injectable tirzepatide price differs between the treatment card and FAQ
- Public homepage does not link to a refund policy or name the dispensing pharmacy
- State-by-state availability is not published on the homepage
Site position #47 · C+
Strengths
- Published plan prices identify their upfront-payment requirement
- Medication, provider access, applicable supplies and shipping included if prescribed
- Compounded injectable semaglutide and oral options listed
What to consider
- The $197 semaglutide headline requires $2,364 upfront, not monthly payments
- Oral program headings and supply descriptions conflict; obtain the selected written quote
- Multi-month balances may remain payable after cancellation; medical-discontinuation refunds require documentation and approval, and dispensed medication is excluded
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.